Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Rizzello

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Inflammatory Bowel Diseases|August 5, 2010
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyLivia Biancone, Carmelina Petruzziello, Ambrogio Orlando, et al.
Advances in Therapy|March 9, 2018
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory DiseaseFernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical ManagementFernando Gomollón, Axel Dignass, Vito Annese, et al.
Journal of Crohn'S & Colitis|March 18, 2014
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohortAmbrogio Orlando, Filippo Mocciaro, Sara Renna, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2021
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in ItalyAlessandro Vitello, Mauro Grova, Daniela Pugliese, et al.
Virchows Archiv : an International Journal of Pathology|May 8, 2021
Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn's disease-associated small bowel carcinomaGiovanni Arpa, Alessandro Vanoli, Federica Grillo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2013
Adalimumab in active ulcerative colitis: a "real-life" observational study, Alessandro Armuzzi, Livia Biancone, et al.
United European Gastroenterology Journal|November 18, 2020
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD studyDaniela Pugliese, Giuseppe Privitera, Francesca Rogai, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Inflammatory Bowel Diseases|August 5, 2010
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair studyLivia Biancone, Carmelina Petruzziello, Ambrogio Orlando, et al.
Advances in Therapy|March 9, 2018
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory DiseaseFernando Rizzello, Ignazio Olivieri, Alessandro Armuzzi, et al.
Journal of Crohn'S & Colitis|September 24, 2016
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical ManagementFernando Gomollón, Axel Dignass, Vito Annese, et al.
Journal of Crohn'S & Colitis|March 18, 2014
Early post-operative endoscopic recurrence in Crohn's disease patients: data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohortAmbrogio Orlando, Filippo Mocciaro, Sara Renna, et al.
Alimentary Pharmacology & Therapeutics|July 25, 2022
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG-IBD LIVE studyDaniela Pugliese, Giuseppe Privitera, Federica Crispino, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 6, 2017
Safety of treatments for inflammatory bowel disease: Clinical practice guidelines of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)Livia Biancone, Vito Annese, Sandro Ardizzone, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 20, 2021
Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in ItalyAlessandro Vitello, Mauro Grova, Daniela Pugliese, et al.
Virchows Archiv : an International Journal of Pathology|May 8, 2021
Prognostic relevance and putative histogenetic role of cytokeratin 7 and MUC5AC expression in Crohn's disease-associated small bowel carcinomaGiovanni Arpa, Alessandro Vanoli, Federica Grillo, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|May 21, 2013
Adalimumab in active ulcerative colitis: a "real-life" observational study, Alessandro Armuzzi, Livia Biancone, et al.
United European Gastroenterology Journal|November 18, 2020
Two-year effectiveness and safety of golimumab in ulcerative colitis: An IG-IBD studyDaniela Pugliese, Giuseppe Privitera, Francesca Rogai, et al.
Pageof 14